Groundbreaking research demonstrates how Nanoscope’s synthetic opsin restores vision in patients with severe retinal degeneration DALLAS, March 24, 2025 /PRNewswire/ — Researchers with Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.